Press Releases
FDA Advisory Committee Supports Approval of Gilead’s Once-Daily Quad Single Tablet Regimen for HIV
– Final FDA Decision On The Quad Anticipated Late Summer – FOSTER CITY, Calif.--(CRWENewswire - Friday May 11, 2012)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Antiviral Drug... [Read more]
Cell Therapeutics’ Pixuvri® Approved in European Union as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas
- Conditional Marketing Authorization Speeds Innovative New Therapy to Patients with Unmet Medical Need SEATTLE, May 10, 2012 (CRWENewswire) -- Cell Therapeutics, Inc.("CTI") (Nasdaq:CTIC) today ann... [Read more]
FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
NEW YORK--(CRWENewswire)--Pfizer Inc. (NYSE:PFE) announced today that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend approval of the investiga... [Read more]
SI Financial Group, Inc. to Initiate Stock Repurchase Program
WILLIMANTIC, Conn., May 8, 2012 (CRWENewswire) -- SI Financial Group, Inc. (the "Company") (Nasdaq:SIFI), the holding company for Savings Institute Bank and Trust Company, announced today that it ha... [Read more]
Israeli Government Awards T3 Motion Two-Year Electric Vehicle Tender
COSTA MESA, Calif., May 8, 2012 (CRWENewswire)-- www.t3motion.com - T3 Motion, Inc. (Amex:TTTM) a producer of clean/green technology, announced that Israel has awarded T3 Motion and its Israeli dist... [Read more]
